ZEMPLAR Drug Patent Profile
✉ Email this page to a colleague
When do Zemplar patents expire, and what generic alternatives are available?
Zemplar is a drug marketed by Abbvie and is included in two NDAs.
The generic ingredient in ZEMPLAR is paricalcitol. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the paricalcitol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zemplar
A generic version of ZEMPLAR was approved as paricalcitol by SANDOZ on July 27th, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZEMPLAR?
- What are the global sales for ZEMPLAR?
- What is Average Wholesale Price for ZEMPLAR?
Summary for ZEMPLAR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 67 |
Clinical Trials: | 63 |
Patent Applications: | 1,758 |
Drug Prices: | Drug price information for ZEMPLAR |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ZEMPLAR |
What excipients (inactive ingredients) are in ZEMPLAR? | ZEMPLAR excipients list |
DailyMed Link: | ZEMPLAR at DailyMed |
Recent Clinical Trials for ZEMPLAR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Emory University | Phase 2 |
Washington University School of Medicine | Phase 1 |
Ipsen | Phase 1 |
Pharmacology for ZEMPLAR
Drug Class | Vitamin D Analog Vitamin D2 Analog |
Paragraph IV (Patent) Challenges for ZEMPLAR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ZEMPLAR | Injection | paricalcitol | 0.002 mg per mL in 1 mL vial and 0.005 mg per mL in 1 mL and 2 mL vials | 020819 | 1 | 2008-11-28 |
ZEMPLAR | Capsules | paricalcitol | 1 mcg and 2 mcg | 021606 | 1 | 2008-10-14 |
ZEMPLAR | Capsules | paricalcitol | 4 mcg | 021606 | 1 | 2008-08-25 |
US Patents and Regulatory Information for ZEMPLAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-001 | May 26, 2005 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | ZEMPLAR | paricalcitol | SOLUTION;INTRAVENOUS | 020819-002 | Feb 1, 2000 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-002 | May 26, 2005 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-003 | May 26, 2005 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZEMPLAR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | ZEMPLAR | paricalcitol | SOLUTION;INTRAVENOUS | 020819-002 | Feb 1, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ZEMPLAR | paricalcitol | SOLUTION;INTRAVENOUS | 020819-003 | Feb 1, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ZEMPLAR | paricalcitol | SOLUTION;INTRAVENOUS | 020819-001 | Apr 17, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | ZEMPLAR | paricalcitol | CAPSULE;ORAL | 021606-002 | May 26, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZEMPLAR
See the table below for patents covering ZEMPLAR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 9702826 | ⤷ Sign Up | |
Japan | H0667899 | ⤷ Sign Up | |
Japan | 2011037860 | COSOLVENT FORMULATION | ⤷ Sign Up |
Canada | 2326198 | FORMULATIONS DE COSOLVANTS (COSOLVENT FORMULATIONS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZEMPLAR
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0387077 | SPC/GB04/003 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: PARICALCITOL; REGISTERED: ES SPAIN 64.974 20020809; UK PL 00037/0403 20030721 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |